CEN Biotech, Inc. (CENBF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
May 2, 2025, 2:12 PM EDT

CEN Biotech Statistics

Total Valuation

CEN Biotech has a market cap or net worth of 6,526.

Market Cap 6,526
Enterprise Value n/a

Important Dates

The last earnings date was Monday, April 28, 2025.

Earnings Date Apr 28, 2025
Ex-Dividend Date n/a

Share Statistics

CEN Biotech has 65.26 million shares outstanding.

Current Share Class n/a
Shares Outstanding 65.26M
Shares Change (YoY) n/a
Shares Change (QoQ) +4.32%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.01
PB Ratio -0.00
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.03

Current Ratio 0.03
Quick Ratio 0.02
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -9.44
Interest Coverage -3.74

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -10.10%
Return on Invested Capital (ROIC) -22.70%
Return on Capital Employed (ROCE) 68.77%
Revenue Per Employee 258,259
Profits Per Employee -773,965
Employee Count 4
Asset Turnover 0.13
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -96.97% in the last 52 weeks. The beta is -78.92, so CEN Biotech's price volatility has been lower than the market average.

Beta (5Y) -78.92
52-Week Price Change -96.97%
50-Day Moving Average 0.00
200-Day Moving Average n/a
Relative Strength Index (RSI) 58.54
Average Volume (20 Days) 271

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.03

Income Statement

In the last 12 months, CEN Biotech had revenue of 1.03 million and -3.10 million in losses. Loss per share was -0.05.

Revenue 1.03M
Gross Profit 1.03M
Operating Income -1.32M
Pretax Income -3.13M
Net Income -3.10M
EBITDA -889,849
EBIT -1.32M
Loss Per Share -0.05
Full Income Statement

Balance Sheet

The company has 148,151 in cash and 5.62 million in debt, giving a net cash position of -5.47 million or -0.08 per share.

Cash & Cash Equivalents 148,151
Total Debt 5.62M
Net Cash -5.47M
Net Cash Per Share -0.08
Equity (Book Value) -2.11M
Book Value Per Share -0.03
Working Capital -9.53M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -590,725 and capital expenditures -4,225, giving a free cash flow of -594,950.

Operating Cash Flow -590,725
Capital Expenditures -4,225
Free Cash Flow -594,950
FCF Per Share -0.01
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -127.54% and -299.69%.

Gross Margin 100.00%
Operating Margin -127.54%
Pretax Margin -303.21%
Profit Margin -299.69%
EBITDA Margin -86.14%
EBIT Margin -127.54%
FCF Margin n/a

Dividends & Yields

CEN Biotech does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -48.69%
Shareholder Yield -48.69%
Earnings Yield -47,438.88%
FCF Yield -9,116.61%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CEN Biotech has an Altman Z-Score of -9.66. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -9.66
Piotroski F-Score n/a